Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 09:54 am Sale |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
3,448,024 5.100% |
-482,893 (-12.28%) |
Filing History |
| 2022-07-11 1:36 pm Sale |
2022-06-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
3,930,917 5.940% |
-2,547,905 (-39.33%) |
Filing History |
| 2022-05-09 5:15 pm Purchase |
2022-04-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 5,680,917 8.100% |
5,016,100 (+754.51%) |
Filing History |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 3,430,154 5.900% |
3,430,154 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 664,817 1.100% |
-3,773,151 (-85.02%) |
Filing History |
| 2022-02-11 4:10 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 5,580,456 9.540% |
1,376,556 (+32.74%) |
Filing History |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
The Vanguard Group | 3,469,317 5.930% |
-366,441 (-9.55%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
3,797,569 6.500% |
387,711 (+11.37%) |
Filing History |
| 2022-02-03 1:46 pm Sale |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
FRANKLIN RESOURCES INC BEN |
5,339 0.000% |
-3,581,500 (-99.85%) |
Filing History |
| 2022-02-02 1:03 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
3,623,245 6.200% |
3,623,245 (New Position) |
Filing History |
| 2022-01-31 1:16 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BANK OF AMERICA CORP BAC |
3,025,313 5.200% |
3,025,313 (New Position) |
Filing History |
| 2022-01-10 10:29 am Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
6,478,822 11.080% |
6,478,822 (New Position) |
Filing History |
| 2021-11-10 4:59 pm Purchase |
2021-11-05 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 4,203,900 7.190% |
4,203,900 (New Position) |
Filing History |
| 2021-02-16 4:07 pm Sale |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 4,437,968 7.800% |
-271,530 (-5.77%) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
The Vanguard Group | 3,835,758 6.740% |
3,835,758 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BLACKROCK INC BLK |
3,409,858 6.000% |
3,409,858 (New Position) |
Filing History |
| 2021-02-01 2:06 pm Purchase |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
FRANKLIN RESOURCES INC BEN |
3,586,839 6.300% |
3,586,839 (New Position) |
Filing History |